Our analysis revealed a novel positive TGFB2-dependent effect of these Gene2 markers on breast cancer survival, whereas previous studies on the expression of these TGFB2-dependent genes focused solely on their impact on either the risk score or as negative prognostic biomarkers. Here, TGFB2 is linked to breast carcinoma.